ask="648.41"
ask_size="100"
average_daily_volume="80289"
bid="0.36"
bid_size="100"
book_value="-91.82"
change="+0.01"
change_from_200_day_moving_average="3.98"
change_from_50_day_moving_average="2.83"
change_from_52_week_high="-0.20"
change_From_52_week_low="6.19"
change_in_percent="+0.05%"
close="18.24"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-41.42"
ebitda="-20.24M"
eps_estimate_current_year="-2.50"
eps_estimate_next_quarter="-0.43"
eps_estimate_next_year="-1.93"
ex_dividend_date="N/A"
float_shares="8856000"
high="18.35"
high_52_weeks="18.44"
last_trade_date="2/6/2017"
last_trade_price="18.24"
last_trade_size="822"
last_trade_time="4:00pm"
low="17.92"
low_52_weeks="12.05"
market_capitalization="411.24M"
moving_average_200_day="14.26"
moving_average_50_day="15.41"
name="Ra Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="25.50"
open="17.98"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+27.89%"
percent_change_from_50_day_moving_average="+18.39%"
percent_change_from_52_week_high="-1.08%"
percent_change_from_52_week_low="+51.36%"
previous_close="18.23"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="71.49"
revenue="5.75M"
shares_outstanding="22546000"
short_ratio="3.28"
stock_exchange="NGM"
symbol="RARX"
volume="26951"
weeks_range_52="12.05 - 18.44"
